Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; a… Read more
Lunai Bioworks Inc. (LNAI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.103x
Based on the latest financial reports, Lunai Bioworks Inc. (LNAI) has a cash flow conversion efficiency ratio of 0.103x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.35 Million) by net assets ($-13.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lunai Bioworks Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Lunai Bioworks Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lunai Bioworks Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lunai Bioworks Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CHINA RAILWAY -H-
MU:CNO
|
N/A |
|
Blackhawk Growth Corp
OTCGREY:BLRZF
|
0.024x |
|
BLUSPRING ENTERPRISES LTD
NSE:BLUSPRING
|
N/A |
|
M.T.I Wireless Edge Ltd
LSE:MWE
|
0.050x |
|
C&R Research Inc.
KO:359090
|
N/A |
|
China Asset Management Co. - China Beijing Affordable Housing Center Rental Housing - Fund
SHG:508068
|
N/A |
|
SITO Mobile Ltd.
PINK:STTO
|
N/A |
|
Nam A Commercial Joint Stock Bank Ordinary Shares
VN:NAB
|
N/A |
Annual Cash Flow Conversion Efficiency for Lunai Bioworks Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Lunai Bioworks Inc. from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-21.35 Million | $-7.87 Million | 0.369x | +543.68% |
| 2024-06-30 | $131.98 Million | $-10.97 Million | -0.083x | +67.17% |
| 2023-06-30 | $46.50 Million | $-11.77 Million | -0.253x | -16.88% |
| 2022-06-30 | $72.62 Million | $-15.73 Million | -0.217x | -83.59% |
| 2021-06-30 | $174.66 Million | $-20.61 Million | -0.118x | -- |